Needham Raises Core Scientific Target to $35 After AMD Deal

Investment bank Needham has raised its price target for Core Scientific shares to $35 following the company's strategic agreement with AMD. The revision reflects expectations that the deal will positively contribute to Core Scientific's growth potential. Analysts believe the collaboration with AMD will strengthen Core Scientific's data center and artificial intelligence infrastructure, thereby improving the company's revenue and profitability outlook. Needham emphasizes that this agreement marks a significant milestone for Core Scientific. The new target price offers substantial upside potential compared to Core Scientific's current trading levels. Needham anticipates that the partnership with AMD will provide a long-term competitive advantage and strengthen the company's position in the industry. This is not investment advice.

📊 AMD — Piyasa Yorumu

▼ down · 70%

AMD shares experienced a sharp decline of over 15% in the last 24 hours, closing at $454.85. While the RSI at 33.37 approaches oversold territory, the MACD remains negative and below its signal line. Trading well below the 20-day and 50-day moving averages ($488.98 and $516.70, respectively) suggests continued short-term pressure. Although the headline news of a Core Scientific price target update is positive, it may not directly impact AMD's own stock performance. Given the weakness in technical indicators and the momentum of the recent decline, the downtrend is likely to persist over the next 1-3 days.

RSI 14

33.4

MACD

-19.45

24h Δ

-15.14%

Canlı Grafikler